Currently, there are several G-quadruplex aptamers which possess a huge therapeutic potential such as AS1411 that targets nucleolin [42] producing cytotoxic effects on cancer cells [43,44] or T40214 that produces antitumorogenic effects in xenografts models [45]. This evidence concerns the gene NUCLEOLIN and cancer.